Lavrov confirms Russia’s commitment to maintain sustainability of Iran nuclear dealRussian Politics & Diplomacy September 21, 4:28
No need to review Iranian nuclear deal - MogheriniWorld September 21, 3:50
Mexico earthquake death toll tops 230World September 21, 3:15
Senior diplomat explains why Moscow did not back US declaration on UN reformRussian Politics & Diplomacy September 21, 2:20
Russia’s proposal on UN mission in Donbass still on the table - Russian diplomatRussian Politics & Diplomacy September 21, 1:42
Putin, Erdogan may have telephone conversation soon — KremlinRussian Politics & Diplomacy September 20, 21:39
Lavrov offers condolences to Mexican people over deadly earthquakesRussian Politics & Diplomacy September 20, 21:01
UN Security Council passes resolution on peacekeeping reformWorld September 20, 20:14
UN peacekeepers should use force only for self-defense — LavrovRussian Politics & Diplomacy September 20, 20:01
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.